Avi sou nondiskriminasyon

Boston Medical Center Health System angaje l bay swen ekitab ak aksesib pou tout moun. Li deklarasyon konplè nou an kont diskriminasyon

The Alpha-1 Center provides comprehensive care for patients and families with alpha-1 antitrypsin deficiency (AATD), the leading genetic cause of emphysema. Our multi-disciplinary team specializes in all aspects of care for AATD, including diagnosis, genetic counseling, and treatment, combining clinical care with research to enhance outcomes.

A department providing care to support lung health and improve breathing for people with for asthma, allergies, COPD, and other breathing conditions.

Yon depatman ki bay swen medikaman GI pou maladi dijestif ak sipò pou jere sentòm ak amelyore sante gastwoentestinal alontèm.

Yon depatman ki bay swen kadyoloji pou maladi kè ak vaskilè pou sipòte sante kè alontèm ak byennèt jeneral.

Edikasyon ak fòmasyon

Pulmonary and Critical Care Fellowship

This three-year program provides training for fellows to become board-certified in both pulmonary medicine and critical care medicine. The fellowship includes clinical care at BMC and the VA Boston Healthcare system, as well as a mentored research project. An optional fourth year focused on research is also available to trainees. 

Apèsi sou rechèch

The Alpha-1 Center is actively involved in both laboratory-based research using patient biological samples and clinical research. Currently, we are initiating the first gene therapy trial for patients with liver complications of alpha-1 deficiency. All patients are evaluated to assess suitability for currently enrolling studies. We counsel patients about and enroll when appropriate in both observational studies and interventional clinical trials. 

Enfòmasyon ou ka bezwen